What Is Fenbendazole and Its Traditional Use?
Fenbendazole is an antiparasitic drug primarily used in veterinary medicine to treat parasites in animals, particularly in dogs, cats, and livestock. It works by interfering with the parasite’s ability to absorb glucose, ultimately leading to their death. While it has proven effective against a variety of parasitic infections, fenbendazole has gained attention in recent years for its potential off-label use in human cancer treatment. Some research suggests that it may inhibit cancer cell growth, leading to growing interest in its potential as an adjunct therapy for certain cancers.

Scientific Research Supporting Fenbendazole’s Role in Cancer
While the evidence is still in its early stages, several studies have explored fenbendazole’s ability to fight cancer cells. Laboratory experiments have shown that fenbendazole can disrupt the microtubules in cancer cells, similar to how chemotherapy drugs like taxanes work. This disruption may prevent cancer cells from dividing and spreading. In animal models, fenbendazole has been associated with tumor shrinkage in various cancers, including those of the lungs, colon, and pancreas. However, it is important to note that these results are not definitive, and human clinical trials are needed to confirm its efficacy and safety in cancer treatment.

Risks and Considerations for Human Use
Despite the promising preclinical findings, fenbendazole is not currently approved for human cancer treatment. It remains a veterinary drug, and its use in humans should only be considered under medical supervision. The safety of fenbendazole in humans has not been fully established, and taking it without proper medical guidance could lead to side effects or interactions with other medications. Anyone considering its use for cancer treatment should consult with their healthcare provider to fully understand the risks and potential benefits. fenbendazol for cancer Portugal